Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hic1
|
ENSMUSG00000043099.4 | hypermethylated in cancer 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_75169782_75170686 | Hic1 | 715 | 0.434273 | 0.35 | 6.8e-03 | Click! |
chr11_75170751_75171074 | Hic1 | 1393 | 0.194883 | -0.32 | 1.2e-02 | Click! |
chr11_75164942_75165185 | Hic1 | 3083 | 0.120737 | -0.13 | 3.3e-01 | Click! |
chr11_75164042_75164228 | Hic1 | 4011 | 0.106550 | -0.07 | 5.8e-01 | Click! |
chr11_75165245_75169157 | Hic1 | 945 | 0.351372 | 0.04 | 7.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_141949754_141950818 | 11.25 |
Brsk2 |
BR serine/threonine kinase 2 |
200 |
0.83 |
chr5_120710211_120711265 | 9.29 |
Dtx1 |
deltex 1, E3 ubiquitin ligase |
1189 |
0.31 |
chr4_124861345_124862773 | 8.67 |
Maneal |
mannosidase, endo-alpha-like |
112 |
0.93 |
chr8_17534365_17535810 | 8.61 |
Csmd1 |
CUB and Sushi multiple domains 1 |
194 |
0.97 |
chr4_125490136_125491914 | 8.33 |
Grik3 |
glutamate receptor, ionotropic, kainate 3 |
325 |
0.89 |
chr12_86989498_86990698 | 8.04 |
Zdhhc22 |
zinc finger, DHHC-type containing 22 |
332 |
0.85 |
chr15_87544354_87545329 | 7.80 |
Tafa5 |
TAFA chemokine like family member 5 |
542 |
0.87 |
chr9_22050521_22051976 | 7.63 |
Elavl3 |
ELAV like RNA binding protein 3 |
762 |
0.41 |
chrX_170674573_170675954 | 7.52 |
Asmt |
acetylserotonin O-methyltransferase |
2619 |
0.41 |
chr11_98327227_98329144 | 7.49 |
Neurod2 |
neurogenic differentiation 2 |
1463 |
0.23 |
chr6_114282516_114283979 | 7.39 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
457 |
0.87 |
chr15_78119178_78120215 | 7.24 |
A730060N03Rik |
RIKEN cDNA A730060N03 gene |
10 |
0.83 |
chr7_99267573_99269343 | 6.71 |
Map6 |
microtubule-associated protein 6 |
52 |
0.95 |
chr9_58197310_58202560 | 6.59 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
637 |
0.54 |
chrX_60892404_60893251 | 6.44 |
Sox3 |
SRY (sex determining region Y)-box 3 |
603 |
0.52 |
chr14_39473185_39473855 | 6.43 |
Nrg3 |
neuregulin 3 |
432 |
0.91 |
chr4_46990869_46991621 | 6.38 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
628 |
0.7 |
chr3_18054443_18055798 | 6.31 |
Bhlhe22 |
basic helix-loop-helix family, member e22 |
946 |
0.58 |
chr2_157914223_157915670 | 6.30 |
Vstm2l |
V-set and transmembrane domain containing 2-like |
293 |
0.91 |
chr2_54436341_54437219 | 6.27 |
Galnt13 |
polypeptide N-acetylgalactosaminyltransferase 13 |
289 |
0.94 |
chr2_70561988_70564432 | 6.25 |
Gad1os |
glutamate decarboxylase 1, opposite strand |
147 |
0.61 |
chr15_75565940_75567228 | 6.10 |
Ly6h |
lymphocyte antigen 6 complex, locus H |
48 |
0.96 |
chr5_110543976_110545228 | 6.02 |
Galnt9 |
polypeptide N-acetylgalactosaminyltransferase 9 |
247 |
0.9 |
chr5_36868663_36870303 | 5.98 |
Ppp2r2c |
protein phosphatase 2, regulatory subunit B, gamma |
820 |
0.55 |
chr15_72546044_72547992 | 5.92 |
Kcnk9 |
potassium channel, subfamily K, member 9 |
678 |
0.75 |
chr2_164967685_164969910 | 5.80 |
Slc12a5 |
solute carrier family 12, member 5 |
516 |
0.7 |
chr15_71727651_71728452 | 5.76 |
Fam135b |
family with sequence similarity 135, member B |
213 |
0.95 |
chr19_47014128_47015152 | 5.53 |
Ina |
internexin neuronal intermediate filament protein, alpha |
58 |
0.88 |
chr9_26733362_26733763 | 5.46 |
B3gat1 |
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
166 |
0.94 |
chr14_24004326_24005118 | 5.45 |
Kcnma1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
137 |
0.68 |
chr7_93079849_93081191 | 5.40 |
Gm9934 |
predicted gene 9934 |
274 |
0.76 |
chr5_130448513_130449808 | 5.39 |
Caln1 |
calneuron 1 |
359 |
0.91 |
chr5_30104769_30106082 | 5.35 |
3110082J24Rik |
RIKEN cDNA 3110082J24 gene |
66 |
0.75 |
chr4_45825879_45827166 | 5.34 |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
401 |
0.81 |
chr8_17532221_17533470 | 5.23 |
Csmd1 |
CUB and Sushi multiple domains 1 |
2436 |
0.46 |
chr16_91226312_91227667 | 5.20 |
Olig2 |
oligodendrocyte transcription factor 2 |
1532 |
0.27 |
chr6_99692136_99693442 | 5.14 |
Gpr27 |
G protein-coupled receptor 27 |
110 |
0.95 |
chr1_72536044_72537425 | 4.99 |
Marchf4 |
membrane associated ring-CH-type finger 4 |
196 |
0.95 |
chr17_28040550_28042470 | 4.96 |
Anks1 |
ankyrin repeat and SAM domain containing 1 |
227 |
0.89 |
chr5_137553079_137554278 | 4.95 |
Actl6b |
actin-like 6B |
121 |
0.89 |
chr3_103575243_103577019 | 4.95 |
Syt6 |
synaptotagmin VI |
5 |
0.98 |
chr7_121391567_121393161 | 4.91 |
Hs3st2 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 2 |
74 |
0.93 |
chr2_158610228_158611991 | 4.90 |
Slc32a1 |
solute carrier family 32 (GABA vesicular transporter), member 1 |
342 |
0.44 |
chr8_94869714_94871671 | 4.86 |
Dok4 |
docking protein 4 |
512 |
0.65 |
chr7_131966504_131967699 | 4.83 |
Gpr26 |
G protein-coupled receptor 26 |
641 |
0.75 |
chr8_12396308_12397229 | 4.83 |
Gm25239 |
predicted gene, 25239 |
365 |
0.77 |
chr15_85670939_85672357 | 4.81 |
Lncppara |
long noncoding RNA near Ppara |
18032 |
0.13 |
chr2_178141581_178143125 | 4.78 |
Phactr3 |
phosphatase and actin regulator 3 |
420 |
0.88 |
chr14_66910135_66911764 | 4.77 |
Pnma2 |
paraneoplastic antigen MA2 |
221 |
0.91 |
chr1_92849002_92850443 | 4.73 |
Mir149 |
microRNA 149 |
656 |
0.43 |
chr8_65617917_65619195 | 4.73 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
31 |
0.99 |
chr9_45430098_45431532 | 4.72 |
4833428L15Rik |
RIKEN cDNA 4833428L15 gene |
417 |
0.52 |
chr14_118235181_118235824 | 4.72 |
Gm4675 |
predicted gene 4675 |
730 |
0.5 |
chrX_99820772_99821586 | 4.66 |
Tmem28 |
transmembrane protein 28 |
158 |
0.97 |
chr5_114090407_114091746 | 4.65 |
Svop |
SV2 related protein |
291 |
0.84 |
chr14_12821743_12822443 | 4.64 |
Cadps |
Ca2+-dependent secretion activator |
952 |
0.63 |
chr7_46396141_46398423 | 4.63 |
Kcnc1 |
potassium voltage gated channel, Shaw-related subfamily, member 1 |
366 |
0.84 |
chr10_81481482_81482676 | 4.61 |
Celf5 |
CUGBP, Elav-like family member 5 |
593 |
0.47 |
chr11_96298885_96301196 | 4.46 |
Hoxb6 |
homeobox B6 |
869 |
0.31 |
chr10_81024569_81025640 | 4.38 |
Gm16099 |
predicted gene 16099 |
21 |
0.8 |
chr16_5884597_5886147 | 4.36 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
17 |
0.99 |
chr8_31089411_31091663 | 4.34 |
Dusp26 |
dual specificity phosphatase 26 (putative) |
733 |
0.65 |
chr11_6604576_6606131 | 4.25 |
Nacad |
NAC alpha domain containing |
700 |
0.46 |
chr5_33996691_33997627 | 4.24 |
Nat8l |
N-acetyltransferase 8-like |
1175 |
0.32 |
chr15_76517568_76519917 | 4.21 |
Scrt1 |
scratch family zinc finger 1 |
3160 |
0.09 |
chr1_174501793_174503606 | 4.18 |
Fmn2 |
formin 2 |
874 |
0.64 |
chr19_10389166_10389986 | 4.18 |
Syt7 |
synaptotagmin VII |
93 |
0.96 |
chr7_44335441_44336039 | 4.17 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
276 |
0.76 |
chr7_24485614_24487418 | 4.17 |
Cadm4 |
cell adhesion molecule 4 |
4493 |
0.1 |
chr10_29146671_29147722 | 4.16 |
Soga3 |
SOGA family member 3 |
139 |
0.95 |
chr17_56474107_56476457 | 4.15 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
655 |
0.65 |
chr19_6497246_6498663 | 4.12 |
Nrxn2 |
neurexin II |
119 |
0.94 |
chr6_113193892_113195750 | 4.11 |
Lhfpl4 |
lipoma HMGIC fusion partner-like protein 4 |
563 |
0.7 |
chr13_109116105_109117683 | 4.09 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
253 |
0.96 |
chr19_36056705_36057845 | 4.05 |
Htr7 |
5-hydroxytryptamine (serotonin) receptor 7 |
65 |
0.98 |
chr13_72629730_72632045 | 4.03 |
Irx2 |
Iroquois homeobox 2 |
1062 |
0.51 |
chr3_87999404_88000408 | 4.00 |
Bcan |
brevican |
272 |
0.82 |
chr3_105451575_105453095 | 4.00 |
Kcnd3 |
potassium voltage-gated channel, Shal-related family, member 3 |
5 |
0.93 |
chr13_54949418_54949943 | 3.99 |
Unc5a |
unc-5 netrin receptor A |
269 |
0.89 |
chr1_176274517_176275808 | 3.99 |
Pld5 |
phospholipase D family, member 5 |
112 |
0.94 |
chr7_138396939_138397631 | 3.98 |
Tcerg1l |
transcription elongation regulator 1-like |
443 |
0.87 |
chr5_69340481_69341683 | 3.98 |
Gm24368 |
predicted gene, 24368 |
299 |
0.7 |
chr2_165233771_165234688 | 3.94 |
Cdh22 |
cadherin 22 |
624 |
0.69 |
chr7_64501626_64502920 | 3.94 |
Apba2 |
amyloid beta (A4) precursor protein-binding, family A, member 2 |
135 |
0.96 |
chr9_45432313_45432910 | 3.93 |
4833428L15Rik |
RIKEN cDNA 4833428L15 gene |
881 |
0.47 |
chr1_74854986_74855602 | 3.91 |
Cdk5r2 |
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
360 |
0.77 |
chr17_47877478_47879368 | 3.89 |
Foxp4 |
forkhead box P4 |
530 |
0.7 |
chr4_124893834_124895373 | 3.89 |
1700125G02Rik |
RIKEN cDNA 1700125G02 gene |
179 |
0.9 |
chr2_24762271_24763479 | 3.86 |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
172 |
0.95 |
chr2_180103356_180104508 | 3.83 |
Hrh3 |
histamine receptor H3 |
219 |
0.89 |
chr15_85576096_85578271 | 3.80 |
Wnt7b |
wingless-type MMTV integration site family, member 7B |
887 |
0.54 |
chr9_117871858_117873400 | 3.79 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
45 |
0.91 |
chr4_148130089_148131325 | 3.77 |
Draxin |
dorsal inhibitory axon guidance protein |
9 |
0.72 |
chr10_127078876_127080327 | 3.74 |
Agap2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
694 |
0.42 |
chr15_74516560_74519631 | 3.73 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
1264 |
0.47 |
chr15_85670346_85670889 | 3.72 |
Lncppara |
long noncoding RNA near Ppara |
17001 |
0.13 |
chr11_80481116_80481835 | 3.71 |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
4419 |
0.21 |
chr18_23309850_23311104 | 3.71 |
Gm7788 |
predicted gene 7788 |
93808 |
0.08 |
chr19_6933255_6934754 | 3.71 |
Kcnk4 |
potassium channel, subfamily K, member 4 |
450 |
0.59 |
chr14_118234662_118235031 | 3.67 |
Gm4675 |
predicted gene 4675 |
1386 |
0.29 |
chr9_60712676_60713877 | 3.65 |
Larp6 |
La ribonucleoprotein domain family, member 6 |
287 |
0.9 |
chr17_56139321_56140590 | 3.64 |
Sema6b |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B |
388 |
0.71 |
chr11_54303826_54304909 | 3.64 |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
165 |
0.94 |
chr10_32889495_32890861 | 3.62 |
Nkain2 |
Na+/K+ transporting ATPase interacting 2 |
283 |
0.94 |
chr1_34750294_34751404 | 3.62 |
Arhgef4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
268 |
0.85 |
chr15_78717784_78718525 | 3.59 |
Elfn2 |
leucine rich repeat and fibronectin type III, extracellular 2 |
41 |
0.97 |
chr8_84415331_84416224 | 3.58 |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
7 |
0.98 |
chr13_54371303_54372670 | 3.58 |
Cplx2 |
complexin 2 |
637 |
0.69 |
chr1_124045018_124046369 | 3.58 |
Dpp10 |
dipeptidylpeptidase 10 |
134 |
0.98 |
chr15_78718540_78719194 | 3.53 |
Elfn2 |
leucine rich repeat and fibronectin type III, extracellular 2 |
96 |
0.96 |
chr15_39198018_39199372 | 3.53 |
Rims2 |
regulating synaptic membrane exocytosis 2 |
332 |
0.87 |
chr12_112143792_112144988 | 3.50 |
Kif26a |
kinesin family member 26A |
1818 |
0.26 |
chr7_4690708_4691898 | 3.47 |
Brsk1 |
BR serine/threonine kinase 1 |
223 |
0.84 |
chr5_144545163_144547007 | 3.46 |
Nptx2 |
neuronal pentraxin 2 |
183 |
0.96 |
chr18_25752531_25753655 | 3.43 |
Celf4 |
CUGBP, Elav-like family member 4 |
401 |
0.88 |
chr5_37241461_37244349 | 3.43 |
Crmp1 |
collapsin response mediator protein 1 |
171 |
0.95 |
chr14_65952886_65954310 | 3.41 |
Scara3 |
scavenger receptor class A, member 3 |
337 |
0.86 |
chr14_12343518_12345314 | 3.41 |
Fezf2 |
Fez family zinc finger 2 |
1428 |
0.3 |
chr13_69738442_69738990 | 3.39 |
Ube2ql1 |
ubiquitin-conjugating enzyme E2Q family-like 1 |
1173 |
0.37 |
chr12_30372306_30373643 | 3.39 |
Sntg2 |
syntrophin, gamma 2 |
291 |
0.93 |
chr11_74589375_74590721 | 3.39 |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
76 |
0.97 |
chr3_94363290_94364465 | 3.38 |
C2cd4d |
C2 calcium-dependent domain containing 4D |
1374 |
0.19 |
chr3_31309226_31310664 | 3.38 |
Slc7a14 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
433 |
0.72 |
chr9_58489768_58490364 | 3.37 |
Insyn1 |
inhibitory synaptic factor 1 |
458 |
0.81 |
chr7_57509014_57510202 | 3.37 |
Gabra5 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5 |
237 |
0.95 |
chr12_67221394_67222796 | 3.36 |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
286 |
0.94 |
chrX_161717059_161718233 | 3.36 |
Rai2 |
retinoic acid induced 2 |
19 |
0.99 |
chr2_151631540_151632560 | 3.34 |
Snph |
syntaphilin |
421 |
0.78 |
chr12_112722274_112723056 | 3.33 |
Cep170b |
centrosomal protein 170B |
471 |
0.67 |
chr4_141367848_141369009 | 3.33 |
Fam131c |
family with sequence similarity 131, member C |
208 |
0.87 |
chr11_118908287_118909561 | 3.32 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
626 |
0.73 |
chr2_25877424_25878675 | 3.31 |
Kcnt1 |
potassium channel, subfamily T, member 1 |
168 |
0.93 |
chr5_38276372_38278048 | 3.29 |
Otop1 |
otopetrin 1 |
194 |
0.92 |
chr3_34648572_34651394 | 3.28 |
Sox2 |
SRY (sex determining region Y)-box 2 |
422 |
0.73 |
chr7_78882466_78883900 | 3.28 |
Mir7-2 |
microRNA 7-2 |
5094 |
0.13 |
chr12_76821715_76823013 | 3.27 |
Rab15 |
RAB15, member RAS oncogene family |
98 |
0.96 |
chr1_132541040_132543287 | 3.27 |
Cntn2 |
contactin 2 |
702 |
0.64 |
chr3_8509825_8511666 | 3.24 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr2_104409773_104410863 | 3.24 |
D430041D05Rik |
RIKEN cDNA D430041D05 gene |
16 |
0.97 |
chr19_48205901_48206676 | 3.22 |
Sorcs3 |
sortilin-related VPS10 domain containing receptor 3 |
263 |
0.94 |
chr11_97574672_97575211 | 3.22 |
Srcin1 |
SRC kinase signaling inhibitor 1 |
274 |
0.87 |
chr11_79590775_79591929 | 3.22 |
Rab11fip4 |
RAB11 family interacting protein 4 (class II) |
140 |
0.93 |
chr5_113490487_113490838 | 3.21 |
Wscd2 |
WSC domain containing 2 |
90 |
0.98 |
chr7_40898734_40899964 | 3.20 |
Vstm2b |
V-set and transmembrane domain containing 2B |
17 |
0.93 |
chr2_180890379_180892235 | 3.18 |
Gm14342 |
predicted gene 14342 |
1647 |
0.19 |
chr12_112928791_112929397 | 3.18 |
Jag2 |
jagged 2 |
646 |
0.51 |
chr14_34819835_34820684 | 3.18 |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
151 |
0.96 |
chr4_152338716_152339639 | 3.18 |
Chd5 |
chromodomain helicase DNA binding protein 5 |
290 |
0.84 |
chr7_16921141_16922156 | 3.18 |
Calm3 |
calmodulin 3 |
2181 |
0.15 |
chr7_81454192_81455460 | 3.17 |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
68 |
0.93 |
chr6_119328752_119331284 | 3.15 |
Lrtm2 |
leucine-rich repeats and transmembrane domains 2 |
739 |
0.43 |
chr9_111311563_111312866 | 3.15 |
Trank1 |
tetratricopeptide repeat and ankyrin repeat containing 1 |
118 |
0.97 |
chr7_44443183_44443767 | 3.15 |
Lrrc4b |
leucine rich repeat containing 4B |
738 |
0.4 |
chr2_25318080_25319601 | 3.15 |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
255 |
0.77 |
chr7_79543154_79544148 | 3.13 |
Gm35040 |
predicted gene, 35040 |
7608 |
0.09 |
chr6_8950297_8950448 | 3.13 |
Nxph1 |
neurexophilin 1 |
696 |
0.81 |
chr14_29721838_29722847 | 3.13 |
Cacna2d3 |
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
478 |
0.79 |
chr1_63445846_63446823 | 3.13 |
Adam23 |
a disintegrin and metallopeptidase domain 23 |
123 |
0.97 |
chr2_156613822_156614400 | 3.11 |
Dlgap4 |
DLG associated protein 4 |
406 |
0.56 |
chr7_57386487_57387529 | 3.11 |
Gabrg3 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3 |
137 |
0.68 |
chrX_86191680_86192868 | 3.11 |
Nr0b1 |
nuclear receptor subfamily 0, group B, member 1 |
510 |
0.82 |
chr15_85580567_85581814 | 3.11 |
AU022754 |
expressed sequence AU022754 |
48 |
0.86 |
chr9_56795792_56797095 | 3.10 |
Lingo1 |
leucine rich repeat and Ig domain containing 1 |
25 |
0.97 |
chr7_4119233_4120703 | 3.10 |
Ttyh1 |
tweety family member 1 |
214 |
0.7 |
chr15_34837199_34838365 | 3.10 |
Kcns2 |
K+ voltage-gated channel, subfamily S, 2 |
267 |
0.93 |
chr1_136259745_136260967 | 3.09 |
Gpr25 |
G protein-coupled receptor 25 |
517 |
0.54 |
chr1_189343295_189344120 | 3.08 |
Kcnk2 |
potassium channel, subfamily K, member 2 |
0 |
0.8 |
chr2_77816072_77817449 | 3.07 |
Zfp385b |
zinc finger protein 385B |
56 |
0.98 |
chr17_8801784_8802345 | 3.07 |
Pde10a |
phosphodiesterase 10A |
285 |
0.93 |
chr19_7421074_7423945 | 3.06 |
Mir6991 |
microRNA 6991 |
64 |
0.94 |
chr4_140245362_140247262 | 3.06 |
Igsf21 |
immunoglobulin superfamily, member 21 |
472 |
0.85 |
chrX_58030987_58032527 | 3.06 |
Zic3 |
zinc finger protein of the cerebellum 3 |
747 |
0.74 |
chr5_38318977_38320095 | 3.06 |
Drd5 |
dopamine receptor D5 |
169 |
0.91 |
chr13_83730601_83731585 | 3.04 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1473 |
0.25 |
chr5_112394558_112394804 | 3.04 |
Asphd2 |
aspartate beta-hydroxylase domain containing 2 |
185 |
0.9 |
chr8_121729721_121730922 | 3.02 |
Jph3 |
junctophilin 3 |
242 |
0.9 |
chr1_165281851_165282801 | 3.01 |
Gpr161 |
G protein-coupled receptor 161 |
13463 |
0.16 |
chr6_91843070_91844089 | 3.00 |
Grip2 |
glutamate receptor interacting protein 2 |
16329 |
0.15 |
chr3_45379351_45381850 | 3.00 |
Pcdh10 |
protocadherin 10 |
2033 |
0.25 |
chrX_140277670_140278583 | 2.99 |
Gm15046 |
predicted gene 15046 |
264 |
0.93 |
chr3_156561493_156562639 | 2.99 |
Negr1 |
neuronal growth regulator 1 |
80 |
0.8 |
chr19_6418703_6419936 | 2.98 |
Nrxn2 |
neurexin II |
554 |
0.44 |
chr12_117153278_117156362 | 2.98 |
Gm10421 |
predicted gene 10421 |
3169 |
0.37 |
chr5_115730943_115731524 | 2.97 |
Bicdl1 |
BICD family like cargo adaptor 1 |
134 |
0.96 |
chr12_105336383_105337702 | 2.97 |
Tunar |
Tcl1 upstream neural differentiation associated RNA |
49 |
0.98 |
chr10_83336995_83338208 | 2.97 |
Slc41a2 |
solute carrier family 41, member 2 |
161 |
0.94 |
chr12_81332229_81333505 | 2.96 |
Slc8a3 |
solute carrier family 8 (sodium/calcium exchanger), member 3 |
92 |
0.97 |
chr5_128432188_128433399 | 2.96 |
Tmem132d |
transmembrane protein 132D |
284 |
0.89 |
chr1_189342678_189343152 | 2.95 |
Kcnk2 |
potassium channel, subfamily K, member 2 |
440 |
0.52 |
chr2_132781102_132782201 | 2.94 |
Chgb |
chromogranin B |
373 |
0.82 |
chr17_56472644_56474083 | 2.94 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
1264 |
0.39 |
chr7_105787327_105787521 | 2.94 |
Dchs1 |
dachsous cadherin related 1 |
128 |
0.92 |
chr7_96210080_96211147 | 2.94 |
Tenm4 |
teneurin transmembrane protein 4 |
24 |
0.98 |
chr10_26077785_26079056 | 2.93 |
Gm9767 |
predicted gene 9767 |
165 |
0.56 |
chr2_74725879_74728683 | 2.93 |
Hoxd4 |
homeobox D4 |
207 |
0.67 |
chr15_79803804_79804650 | 2.93 |
Nptxr |
neuronal pentraxin receptor |
482 |
0.67 |
chr9_58822402_58824154 | 2.93 |
Hcn4 |
hyperpolarization-activated, cyclic nucleotide-gated K+ 4 |
134 |
0.97 |
chr2_181134042_181135583 | 2.92 |
Kcnq2 |
potassium voltage-gated channel, subfamily Q, member 2 |
110 |
0.95 |
chr12_111671006_111672264 | 2.92 |
Ckb |
creatine kinase, brain |
91 |
0.94 |
chr11_81151880_81152516 | 2.91 |
Asic2 |
acid-sensing (proton-gated) ion channel 2 |
1123 |
0.62 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 10.0 | GO:0021586 | pons maturation(GO:0021586) |
2.3 | 20.4 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
2.2 | 29.2 | GO:0071625 | vocalization behavior(GO:0071625) |
2.2 | 6.5 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
2.2 | 4.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.0 | 6.1 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
2.0 | 12.0 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
2.0 | 3.9 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.9 | 7.7 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
1.9 | 7.6 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
1.8 | 5.3 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
1.7 | 8.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.7 | 5.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.7 | 5.1 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.7 | 5.0 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.7 | 5.0 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
1.7 | 5.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.6 | 1.6 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
1.6 | 4.9 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
1.6 | 1.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.5 | 13.5 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
1.5 | 4.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.5 | 4.4 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.4 | 7.2 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.4 | 4.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.4 | 2.8 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.4 | 2.7 | GO:0046959 | habituation(GO:0046959) |
1.3 | 2.7 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
1.3 | 4.0 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
1.3 | 4.0 | GO:0015888 | thiamine transport(GO:0015888) |
1.3 | 3.9 | GO:0050975 | sensory perception of touch(GO:0050975) |
1.3 | 3.9 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.3 | 2.6 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
1.3 | 5.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.3 | 10.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.2 | 2.5 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.2 | 2.5 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
1.2 | 4.9 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
1.2 | 4.9 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
1.2 | 7.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
1.2 | 9.7 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.2 | 3.6 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.2 | 3.6 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.2 | 3.6 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.2 | 3.6 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.2 | 2.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.1 | 3.4 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
1.1 | 9.0 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
1.1 | 3.3 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
1.1 | 5.5 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
1.1 | 25.2 | GO:0001964 | startle response(GO:0001964) |
1.1 | 5.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.0 | 2.1 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
1.0 | 4.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.0 | 1.0 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
1.0 | 3.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.0 | 21.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.0 | 3.1 | GO:0009629 | response to gravity(GO:0009629) |
1.0 | 5.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.0 | 2.0 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
1.0 | 4.0 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
1.0 | 4.0 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
1.0 | 3.0 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.0 | 16.7 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.9 | 1.9 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.9 | 3.8 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.9 | 2.8 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.9 | 4.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.9 | 2.8 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.9 | 2.8 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.9 | 2.8 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.9 | 4.6 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.9 | 2.7 | GO:0021825 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) substrate-dependent cerebral cortex tangential migration(GO:0021825) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
0.9 | 1.8 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.9 | 2.7 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.9 | 2.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.9 | 5.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.9 | 7.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.9 | 6.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.9 | 1.7 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.9 | 11.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.8 | 5.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.8 | 4.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.8 | 3.4 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.8 | 3.4 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.8 | 1.7 | GO:0035106 | operant conditioning(GO:0035106) |
0.8 | 3.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.8 | 5.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.8 | 3.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.8 | 2.5 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.8 | 0.8 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.8 | 1.7 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.8 | 2.4 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.8 | 1.6 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.8 | 2.4 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.8 | 13.6 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.8 | 3.9 | GO:0060174 | limb bud formation(GO:0060174) |
0.8 | 3.9 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.8 | 3.9 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.8 | 6.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.8 | 3.1 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.8 | 0.8 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.8 | 1.5 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.8 | 3.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.8 | 1.5 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.8 | 39.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.8 | 1.5 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.7 | 0.7 | GO:0036166 | phenotypic switching(GO:0036166) |
0.7 | 6.6 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.7 | 2.9 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.7 | 0.7 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.7 | 7.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.7 | 1.4 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.7 | 9.9 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.7 | 5.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.7 | 2.8 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.7 | 0.7 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.7 | 2.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.7 | 2.8 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.7 | 0.7 | GO:0046958 | nonassociative learning(GO:0046958) |
0.7 | 2.7 | GO:0030432 | peristalsis(GO:0030432) |
0.7 | 4.1 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.7 | 2.0 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.7 | 2.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.7 | 3.9 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.7 | 6.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.6 | 2.6 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.6 | 0.6 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.6 | 0.6 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.6 | 2.6 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.6 | 1.9 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.6 | 2.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.6 | 0.6 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.6 | 3.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.6 | 3.7 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.6 | 1.2 | GO:0003195 | tricuspid valve morphogenesis(GO:0003186) mitral valve formation(GO:0003192) tricuspid valve formation(GO:0003195) |
0.6 | 11.7 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.6 | 0.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.6 | 10.2 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.6 | 1.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.6 | 1.8 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.6 | 2.4 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.6 | 1.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.6 | 7.6 | GO:0035640 | exploration behavior(GO:0035640) |
0.6 | 1.2 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.6 | 2.3 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.6 | 4.7 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.6 | 1.2 | GO:0072034 | renal vesicle induction(GO:0072034) |
0.6 | 1.7 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.6 | 0.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.6 | 1.7 | GO:1903416 | response to glycoside(GO:1903416) |
0.6 | 1.1 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.6 | 1.7 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.6 | 1.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.6 | 1.1 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.6 | 2.3 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.6 | 3.4 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.6 | 2.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.6 | 2.8 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.6 | 2.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.6 | 1.7 | GO:0060437 | lung growth(GO:0060437) |
0.5 | 2.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 1.1 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.5 | 1.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.5 | 0.5 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.5 | 3.3 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.5 | 2.7 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.5 | 1.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 1.1 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.5 | 2.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.5 | 1.6 | GO:1902075 | cellular response to salt(GO:1902075) |
0.5 | 7.5 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.5 | 1.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.5 | 2.1 | GO:0003383 | apical constriction(GO:0003383) |
0.5 | 1.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.5 | 3.7 | GO:0071435 | potassium ion export(GO:0071435) |
0.5 | 1.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.5 | 1.1 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.5 | 1.1 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.5 | 1.6 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.5 | 3.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.5 | 2.1 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.5 | 1.0 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.5 | 1.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.5 | 2.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.5 | 1.5 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.5 | 0.5 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.5 | 3.6 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.5 | 1.0 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.5 | 1.5 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.5 | 1.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.5 | 2.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.5 | 1.0 | GO:0032898 | neurotrophin production(GO:0032898) |
0.5 | 2.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.5 | 1.4 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.5 | 4.8 | GO:0015816 | glycine transport(GO:0015816) |
0.5 | 0.5 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.5 | 0.9 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.5 | 1.9 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.5 | 0.5 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.5 | 1.9 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.5 | 3.3 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) regulation of glutamate receptor signaling pathway(GO:1900449) |
0.5 | 28.9 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.5 | 1.4 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.5 | 2.3 | GO:0071420 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.5 | 1.4 | GO:0097503 | sialylation(GO:0097503) |
0.5 | 0.5 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.5 | 1.4 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.5 | 0.5 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.5 | 0.9 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.5 | 0.5 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.5 | 3.2 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.5 | 2.7 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.5 | 0.9 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.4 | 1.3 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.4 | 0.4 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.4 | 1.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.4 | 5.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.4 | 0.9 | GO:0007412 | axon target recognition(GO:0007412) |
0.4 | 0.9 | GO:0008355 | olfactory learning(GO:0008355) |
0.4 | 2.6 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.4 | 1.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.4 | 0.4 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.4 | 6.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.4 | 2.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.4 | 2.6 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.4 | 1.7 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.4 | 3.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.4 | 1.3 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.4 | 1.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.4 | 0.4 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.4 | 2.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.4 | 2.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.4 | 2.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.4 | 0.4 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.4 | 0.8 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.4 | 1.2 | GO:0015755 | fructose transport(GO:0015755) |
0.4 | 2.9 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.4 | 0.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 1.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.4 | 30.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 0.8 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.4 | 0.8 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.4 | 1.2 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.4 | 1.2 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.4 | 1.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.4 | 7.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 | 1.2 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.4 | 1.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.4 | 1.5 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.4 | 3.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.4 | 0.4 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.4 | 2.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 0.8 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.4 | 1.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.4 | 0.7 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.4 | 2.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.4 | 0.4 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.4 | 3.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.4 | 3.3 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.4 | 1.1 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.4 | 0.7 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.4 | 3.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 1.1 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.4 | 0.4 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.4 | 2.9 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.4 | 1.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.4 | 0.4 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.4 | 1.1 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.4 | 2.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.4 | 1.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.4 | 17.2 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.3 | 0.3 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.3 | 0.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.3 | 1.0 | GO:0072017 | distal tubule development(GO:0072017) |
0.3 | 2.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 1.0 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.3 | 1.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.3 | 1.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.3 | 1.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 1.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.3 | 1.7 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.3 | 0.7 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.3 | 0.7 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.3 | 0.3 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.3 | 3.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.3 | 0.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 0.7 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.3 | 1.7 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.3 | 1.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.3 | 1.3 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.3 | 0.7 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.3 | 1.0 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.3 | 1.0 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.3 | 1.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.3 | 0.3 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.3 | 1.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.3 | 1.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.3 | 1.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.3 | 1.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.3 | 1.9 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.3 | 1.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.3 | 0.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 0.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.3 | 1.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.3 | 0.6 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.3 | 0.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.3 | 0.3 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.3 | 0.6 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 0.6 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.3 | 0.6 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.3 | 0.6 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 1.5 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.3 | 5.8 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.3 | 1.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.3 | 1.2 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.3 | 0.6 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.3 | 1.5 | GO:0007614 | short-term memory(GO:0007614) |
0.3 | 1.2 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.3 | 0.6 | GO:0035989 | tendon development(GO:0035989) |
0.3 | 1.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.3 | 0.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 0.9 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 0.9 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 1.2 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.3 | 0.6 | GO:0051665 | membrane raft localization(GO:0051665) |
0.3 | 0.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.3 | 0.9 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 1.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.3 | 0.9 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 4.0 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.3 | 1.1 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.3 | 0.6 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.3 | 0.8 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.3 | 5.0 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.3 | 0.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 0.3 | GO:0061743 | motor learning(GO:0061743) |
0.3 | 4.7 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.3 | 0.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 1.9 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.3 | 0.8 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.3 | 0.5 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.3 | 0.3 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.3 | 0.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 4.3 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.3 | 0.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.3 | 1.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.3 | 0.8 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.3 | 0.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 0.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 0.5 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 0.3 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.3 | 0.8 | GO:0022038 | corpus callosum development(GO:0022038) |
0.3 | 0.8 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.3 | 0.5 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.3 | 0.3 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.3 | 0.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.3 | 2.3 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.3 | 0.5 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.3 | 1.8 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.3 | 0.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 1.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 0.5 | GO:0003358 | noradrenergic neuron development(GO:0003358) sympathetic ganglion development(GO:0061549) |
0.3 | 4.6 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.3 | 0.5 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.3 | 1.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 0.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 3.0 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 6.7 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 2.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 1.0 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 0.7 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 2.7 | GO:0030815 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) negative regulation of cAMP metabolic process(GO:0030815) |
0.2 | 0.2 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.2 | 1.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 0.7 | GO:0042220 | response to cocaine(GO:0042220) |
0.2 | 1.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.5 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.2 | 1.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 0.7 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.2 | 0.2 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.2 | 0.7 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 0.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 0.7 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.2 | 0.2 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 0.5 | GO:0031223 | auditory behavior(GO:0031223) |
0.2 | 0.5 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.2 | 0.7 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.2 | 0.5 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 0.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 1.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 2.3 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.2 | 0.7 | GO:0042637 | catagen(GO:0042637) |
0.2 | 3.5 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.2 | 0.7 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.2 | 0.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.5 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.2 | 2.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 0.9 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.9 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.2 | 2.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 0.5 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 1.4 | GO:0042756 | drinking behavior(GO:0042756) |
0.2 | 2.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 1.4 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.2 | 0.7 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.2 | 2.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.4 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.2 | 0.7 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 1.5 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 1.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 1.3 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
0.2 | 0.9 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.6 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.2 | 0.4 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.2 | 1.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.6 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 0.8 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.2 | 14.2 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.2 | 1.5 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.2 | 0.6 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.2 | 0.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 1.9 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 1.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 0.6 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 1.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.4 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.2 | 0.6 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.4 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.2 | 3.7 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 1.2 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.2 | 1.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 1.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.2 | 9.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.2 | 1.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 3.4 | GO:0008306 | associative learning(GO:0008306) |
0.2 | 2.2 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.2 | 0.6 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 1.2 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 3.4 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.2 | 0.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 4.1 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.2 | 7.6 | GO:0050905 | neuromuscular process(GO:0050905) |
0.2 | 1.2 | GO:0060004 | reflex(GO:0060004) |
0.2 | 1.9 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 7.6 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.2 | 0.4 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 0.8 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.2 | 1.5 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.2 | 0.6 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 2.8 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.2 | 1.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.7 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 0.9 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 0.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 1.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 0.5 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 1.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 3.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.4 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 0.4 | GO:0090148 | membrane fission(GO:0090148) |
0.2 | 2.9 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.2 | 0.2 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.2 | 1.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 3.6 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.2 | 3.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 1.5 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.5 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.2 | 0.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 1.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.2 | 1.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 1.8 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.2 | 0.3 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.2 | 0.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 0.6 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.2 | 0.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.2 | 0.6 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.2 | 2.5 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.2 | 0.8 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 0.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.3 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.2 | 0.9 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.2 | 0.3 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 0.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 2.3 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.2 | 0.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.3 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.2 | 0.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 0.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.1 | GO:0071288 | cellular response to copper ion(GO:0071280) cellular response to mercury ion(GO:0071288) |
0.1 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.3 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 0.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.4 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.6 | GO:1900113 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.1 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.1 | 1.9 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.1 | 1.0 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.7 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 5.0 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 1.1 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.4 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 0.1 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.1 | 0.1 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.1 | 0.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.5 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
0.1 | 0.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.1 | GO:0003129 | heart induction(GO:0003129) |
0.1 | 0.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.5 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 1.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.3 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 1.3 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.2 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.1 | 0.2 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.4 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.4 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 1.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.4 | GO:0086009 | membrane repolarization(GO:0086009) |
0.1 | 0.1 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.1 | 0.4 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.5 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.6 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.1 | 0.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.1 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.1 | 0.6 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.2 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.2 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 0.3 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.4 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 1.7 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 0.3 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 1.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 1.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 1.4 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 2.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.1 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.1 | 0.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.3 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.2 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.9 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.2 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.3 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.5 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.2 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.1 | 0.4 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.1 | 0.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.3 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.1 | 0.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.2 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.1 | 0.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.2 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.1 | 0.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.3 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 1.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.4 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.2 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.2 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.3 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.1 | 0.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.1 | GO:0097061 | dendritic spine organization(GO:0097061) |
0.1 | 2.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.3 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.7 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.9 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.1 | 0.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.3 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 0.2 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.1 | 0.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.7 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.6 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 0.2 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.4 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.1 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.1 | 0.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.5 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.4 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.1 | 2.8 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.6 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 0.4 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.2 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 1.4 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.3 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.2 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 1.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.5 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.1 | 0.2 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.9 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 0.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 0.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.2 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.2 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.1 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.3 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.3 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.1 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 0.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.9 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.4 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.4 | GO:0010878 | cholesterol storage(GO:0010878) |
0.1 | 0.8 | GO:0097480 | synaptic vesicle transport(GO:0048489) establishment of synaptic vesicle localization(GO:0097480) |
0.1 | 0.2 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 0.5 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.2 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 0.2 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.1 | 0.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.6 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.1 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.1 | 0.3 | GO:0048846 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.1 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.8 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.2 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.2 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.1 | 0.1 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.1 | 0.1 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 0.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.1 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.8 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.1 | 0.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.1 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.1 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.2 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 3.4 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.1 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.1 | 0.5 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 0.8 | GO:0048678 | response to axon injury(GO:0048678) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.1 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.1 | 0.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.1 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.1 | 0.1 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.1 | 0.3 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 0.2 | GO:1903671 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.1 | GO:0090135 | actin filament branching(GO:0090135) |
0.1 | 0.3 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.1 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.0 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.0 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.2 | GO:0018158 | protein oxidation(GO:0018158) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.2 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.0 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.2 | GO:0036344 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.0 | 0.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.0 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.1 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.0 | 0.1 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.2 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.2 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.0 | 0.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.0 | 0.0 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.0 | 0.0 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.1 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.2 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.1 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.0 | 0.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.0 | 0.1 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.0 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.2 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.5 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.0 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.6 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.2 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) negative regulation of bone resorption(GO:0045779) |
0.0 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.3 | GO:0021766 | hippocampus development(GO:0021766) |
0.0 | 0.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.4 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.0 | 0.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.0 | 0.5 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.0 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.0 | 0.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.2 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 0.5 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.3 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.0 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.0 | 0.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.1 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.0 | 0.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.2 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.0 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.0 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.1 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.0 | 0.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.1 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.0 | 0.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.9 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.0 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.0 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.0 | 0.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.2 | GO:0051181 | cofactor transport(GO:0051181) |
0.0 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.0 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.0 | 0.3 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.8 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.2 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.0 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.0 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
0.0 | 0.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.4 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 0.5 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.1 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.0 | 0.1 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.0 | 0.1 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.1 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.0 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.0 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 0.0 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.0 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.0 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.0 | 0.0 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.0 | 0.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.1 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 0.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.2 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.1 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.0 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.0 | 0.0 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.1 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.0 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.0 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.0 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.0 | 0.2 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 0.0 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.0 | 0.1 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.0 | GO:0086066 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.0 | 0.0 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.0 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 0.1 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.0 | 0.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 0.0 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
0.0 | 0.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.0 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.0 | 0.0 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.0 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.0 | 0.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.2 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.0 | 0.7 | GO:0098792 | xenophagy(GO:0098792) |
0.0 | 0.1 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.0 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.0 | 0.0 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.0 | 0.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.0 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.0 | 0.0 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.2 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
2.5 | 7.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.8 | 8.8 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.6 | 1.6 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.5 | 10.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.5 | 9.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.4 | 15.8 | GO:0043194 | axon initial segment(GO:0043194) |
1.4 | 11.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.4 | 1.4 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
1.3 | 11.9 | GO:0005883 | neurofilament(GO:0005883) |
1.2 | 1.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.2 | 10.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.2 | 1.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.1 | 15.7 | GO:0030673 | axolemma(GO:0030673) |
1.1 | 13.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.1 | 24.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.1 | 31.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.0 | 1.0 | GO:0032279 | asymmetric synapse(GO:0032279) |
1.0 | 24.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.9 | 4.7 | GO:0043219 | lateral loop(GO:0043219) |
0.9 | 23.5 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.9 | 3.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.9 | 2.7 | GO:0032280 | symmetric synapse(GO:0032280) |
0.8 | 0.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.8 | 29.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.8 | 2.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.8 | 13.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.8 | 2.4 | GO:0072534 | perineuronal net(GO:0072534) |
0.8 | 3.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.8 | 9.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.7 | 3.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 2.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.7 | 36.6 | GO:0034705 | potassium channel complex(GO:0034705) |
0.7 | 7.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.6 | 2.5 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.6 | 4.8 | GO:0071437 | invadopodium(GO:0071437) |
0.6 | 84.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.5 | 1.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.5 | 1.4 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.5 | 9.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.5 | 1.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.5 | 2.4 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.5 | 0.5 | GO:0016342 | catenin complex(GO:0016342) |
0.5 | 5.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 3.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 1.6 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.4 | 44.3 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.4 | 1.6 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.4 | 0.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 1.9 | GO:0097433 | dense body(GO:0097433) |
0.4 | 3.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 1.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.4 | 1.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 1.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.4 | 1.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.3 | 1.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 1.7 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 2.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 0.7 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 1.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.3 | 1.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 1.7 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 6.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.3 | 0.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 4.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 1.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.3 | 0.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.3 | 0.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 1.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 0.3 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 2.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 4.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 13.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.3 | 2.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 2.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 3.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 40.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 0.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 2.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 0.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 3.2 | GO:0034706 | sodium channel complex(GO:0034706) |
0.3 | 0.5 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.3 | 9.2 | GO:0043679 | axon terminus(GO:0043679) |
0.3 | 0.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 1.0 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.3 | 4.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 1.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 2.7 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 0.5 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.2 | 0.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 0.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 0.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 0.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 2.9 | GO:0097060 | synaptic membrane(GO:0097060) |
0.2 | 1.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 11.5 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 12.5 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 0.9 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 0.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 5.4 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 0.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 47.5 | GO:0045202 | synapse(GO:0045202) |
0.2 | 0.8 | GO:0000235 | astral microtubule(GO:0000235) |
0.2 | 1.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 1.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 4.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 3.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 0.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 0.6 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 2.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 4.3 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 1.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 4.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.5 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 38.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 1.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.1 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 0.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 4.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.4 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 7.1 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 0.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 2.8 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 5.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 40.5 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 1.5 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.6 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.5 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 1.4 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 1.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 1.7 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.2 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.7 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.6 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 2.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.5 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.3 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 2.9 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 4.5 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 337.3 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 1.1 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.1 | GO:1990752 | microtubule end(GO:1990752) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 3.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.1 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.6 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.3 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.1 | GO:1903349 | extrinsic component of omegasome membrane(GO:0097629) omegasome membrane(GO:1903349) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 2.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 1.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.2 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 0.1 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 2.0 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 2.4 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 6.3 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.4 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.1 | GO:0070187 | telosome(GO:0070187) |
0.0 | 1.0 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.2 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 2.0 | GO:0099503 | secretory vesicle(GO:0099503) |
0.0 | 0.4 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.6 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.0 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.0 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.0 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
3.0 | 8.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
2.3 | 16.2 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
2.3 | 11.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
2.2 | 6.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.8 | 7.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.8 | 5.3 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.8 | 5.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.8 | 5.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.7 | 5.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
1.7 | 1.7 | GO:0038191 | neuropilin binding(GO:0038191) |
1.6 | 4.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.6 | 6.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.6 | 4.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.6 | 4.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.6 | 6.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.6 | 3.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.5 | 4.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.4 | 7.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.4 | 11.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.4 | 5.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.3 | 4.0 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) alpha2-adrenergic receptor activity(GO:0004938) |
1.1 | 5.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.1 | 5.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.1 | 12.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.1 | 8.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.0 | 9.4 | GO:0030553 | cGMP binding(GO:0030553) |
1.0 | 1.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.0 | 5.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.0 | 3.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.0 | 15.0 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
1.0 | 4.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.0 | 3.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
1.0 | 6.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.0 | 2.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.0 | 2.9 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.0 | 2.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.9 | 30.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.9 | 16.3 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.9 | 4.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.9 | 4.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.9 | 3.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.9 | 2.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.8 | 2.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.8 | 5.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.8 | 2.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.8 | 3.2 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.8 | 9.4 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.8 | 4.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.8 | 11.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.7 | 3.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.7 | 8.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.7 | 18.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.7 | 7.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.7 | 4.4 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.7 | 3.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.7 | 1.4 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.7 | 2.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.7 | 9.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.6 | 11.0 | GO:0005112 | Notch binding(GO:0005112) |
0.6 | 4.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.6 | 1.9 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.6 | 8.9 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.6 | 1.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.6 | 2.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.6 | 2.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.6 | 1.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.6 | 1.2 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.6 | 0.6 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.6 | 3.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.6 | 1.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.6 | 1.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.6 | 7.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.6 | 10.0 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.6 | 3.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.6 | 14.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.6 | 1.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.6 | 1.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.6 | 24.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.6 | 11.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.6 | 0.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.6 | 2.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.5 | 2.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.5 | 1.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 2.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 2.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.5 | 6.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 1.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.5 | 6.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.5 | 2.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.5 | 11.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.5 | 1.5 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.5 | 13.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.5 | 1.9 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.5 | 1.9 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 1.4 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.5 | 8.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.5 | 3.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.5 | 18.7 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.5 | 8.6 | GO:0052736 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.4 | 1.3 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.4 | 5.3 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 2.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 1.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 1.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 5.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.4 | 5.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 4.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 1.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 0.8 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.4 | 4.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.4 | 2.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 1.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 0.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.4 | 2.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.4 | 5.1 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.4 | 1.9 | GO:0034711 | inhibin binding(GO:0034711) |
0.4 | 1.5 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.4 | 0.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 0.8 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.4 | 7.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 1.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.4 | 1.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.4 | 1.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.4 | 10.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.4 | 1.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.4 | 1.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 3.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.4 | 7.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.4 | 1.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.4 | 2.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 1.0 | GO:2001070 | starch binding(GO:2001070) |
0.3 | 1.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 3.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 1.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 8.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 0.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.3 | 9.1 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.3 | 2.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 1.6 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.3 | 2.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 3.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.3 | 1.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 0.9 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.3 | 0.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 3.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.3 | 12.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.3 | 1.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 0.9 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 3.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 0.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 0.9 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 1.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 1.2 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.3 | 6.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 1.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.3 | 4.9 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.3 | 3.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.3 | 1.7 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.3 | 28.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.3 | 5.1 | GO:0052714 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.3 | 2.5 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.3 | 2.8 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.3 | 0.3 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.3 | 1.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 0.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 0.8 | GO:0004103 | choline kinase activity(GO:0004103) |
0.3 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 5.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.3 | 0.8 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.3 | 0.8 | GO:0031402 | sodium ion binding(GO:0031402) |
0.3 | 9.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.3 | 1.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.3 | 1.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 0.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.3 | 1.8 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 0.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 1.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.3 | 1.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.3 | 3.8 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.2 | 2.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 3.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 1.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.7 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 4.4 | GO:0005267 | potassium channel activity(GO:0005267) |
0.2 | 1.2 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.2 | 1.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 0.7 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.2 | 2.2 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.2 | 0.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.5 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.2 | 3.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 0.2 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.2 | 1.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 0.9 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 0.4 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 1.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 1.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 0.2 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 0.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 3.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 1.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 1.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.2 | 1.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 0.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 0.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 4.8 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.2 | 10.4 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 0.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 5.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.4 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 0.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 1.8 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.2 | 3.8 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 0.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 1.0 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 1.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 0.8 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.2 | 1.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 1.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 0.7 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 4.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 0.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 0.4 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.7 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 1.9 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 1.8 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.2 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 3.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 0.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 1.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.7 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 0.8 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 2.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 1.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.2 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 1.6 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 0.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 0.5 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 0.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 9.0 | GO:0044325 | ion channel binding(GO:0044325) |
0.2 | 3.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 0.2 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.2 | 0.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 0.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.8 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.3 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 3.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 1.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.7 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 1.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 3.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 3.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 3.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 1.1 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.3 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) epinephrine binding(GO:0051379) norepinephrine binding(GO:0051380) |
0.1 | 3.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 4.3 | GO:0034792 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.1 | 0.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 57.4 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 2.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.9 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.4 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 1.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 5.4 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.8 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.1 | 0.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.2 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.7 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.5 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.4 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 1.7 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) urea channel activity(GO:0015265) |
0.1 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 1.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 1.2 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 0.9 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.8 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 3.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.5 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.9 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.6 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 2.0 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 1.8 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.3 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 2.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 6.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 2.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.7 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 2.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.5 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 0.3 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 1.4 | GO:0042562 | hormone binding(GO:0042562) |
0.1 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.6 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.1 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.1 | 0.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 4.3 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.2 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.1 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 9.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.9 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.8 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 6.6 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 31.6 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 1.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.2 | GO:0001032 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 0.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.2 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 0.8 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.9 | GO:0016247 | channel regulator activity(GO:0016247) |
0.1 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.5 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 4.5 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.3 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.1 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.8 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 1.7 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 1.1 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.1 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.0 | GO:0005119 | smoothened binding(GO:0005119) |
0.0 | 8.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.4 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.0 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.0 | 3.5 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 1.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 2.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.0 | 0.4 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 1.0 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.2 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.1 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.0 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.0 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.6 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.0 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.2 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.0 | 0.0 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.0 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.0 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.2 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.0 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) flap endonuclease activity(GO:0048256) |
0.0 | 0.0 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.0 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.0 | GO:0050997 | quaternary ammonium group binding(GO:0050997) |
0.0 | 0.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.5 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 17.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.6 | 0.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.6 | 1.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.4 | 8.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.4 | 5.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 11.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 0.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 11.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 1.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 2.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 5.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 4.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 6.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 7.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 8.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 2.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 32.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 5.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 1.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 3.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 37.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 5.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 6.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 4.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 6.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 5.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 2.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 4.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 0.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 0.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 1.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 1.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 2.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 25.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.9 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 2.2 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 3.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 2.6 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 2.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 4.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 15.3 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 0.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 1.4 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
1.4 | 15.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.3 | 18.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.2 | 19.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.1 | 12.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.9 | 39.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.9 | 9.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.8 | 28.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.7 | 6.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.7 | 9.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.7 | 9.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 2.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.6 | 9.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.6 | 5.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.6 | 11.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.6 | 8.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 14.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.6 | 6.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.6 | 10.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.5 | 20.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.5 | 10.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.5 | 5.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.5 | 5.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 4.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.5 | 5.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.5 | 3.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.5 | 11.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 1.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.4 | 2.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.4 | 5.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 4.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.4 | 0.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.4 | 13.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 6.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.3 | 0.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.3 | 1.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 8.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 0.6 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.3 | 0.6 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.3 | 3.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 5.9 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.3 | 1.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.3 | 18.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 11.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 2.7 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 0.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.2 | 0.5 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.2 | 1.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 0.9 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 3.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 7.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 1.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 4.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 2.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 1.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 2.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 1.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 1.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 3.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 1.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 1.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.2 | 2.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 2.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 1.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 0.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 9.2 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.2 | 3.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 0.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 0.3 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 0.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 0.7 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.2 | 1.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 1.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 4.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.4 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.1 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 19.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 1.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 2.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 4.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 3.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 2.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 2.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 3.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 2.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 4.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 6.8 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.8 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.1 | 0.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 8.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 3.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 1.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 2.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.7 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 2.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.1 | REACTOME SEMAPHORIN INTERACTIONS | Genes involved in Semaphorin interactions |
0.1 | 0.9 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 1.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 0.3 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.1 | 0.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.0 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.0 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 1.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.2 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.0 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |